You’re in control with flexible, data-driven drug product formulation and manufacturing.
Achieve your molecule’s next milestone with fit-for-phase drug product formulation and drug product manufacturing services, backed by trusted data and the insight you need to navigate the increasing complexity of small molecule and synthetic peptide therapeutics.
Quotient Sciences streamlines the transitions between each development stage to help you bring your drug product to your next milestone efficiently, with no compromises to safety or quality.
Over 30 years of experience
in drug product formulation and drug product manufacturing, at all stages of development.
Scalable manufacturing that fits your program
from smaller batch sizes to support clinical trial materials, up to 500 kg for solid oral dosage forms in commercial drug product.
Trusted by leading global companies
including Fortune 100 large pharmaceutical companies and emerging biotechs.
Achieve your molecule’s full potential with our extensive experience in developing & manufacturing drug product
Tailored drug product formulation and manufacturing strategies that are fit-for-phase, backed by trusted data and the insight you need to navigate the increasing complexity of drug development.
We can help you with drug product solutions that:
- Maximize Efficiency
Our teams utilize a range of technologies alongside proven strategies for navigating development in the most efficient way possible.
- Bridge the Gaps
Our focus is always phase-appropriate. That means we personalize support for your drug program today while looking ahead to future milestones.
- Stay in Control
Our goal is to keep you on-course as you scale up—from registration to commercial batches and beyond, with capabilities to provide a reliable, continued commercial supply that you can trust.
Keeping you in control at every stage. Learn about our flexible, phase-appropriate services for drug product development and manufacturing.
Meet Our Drug Product Experts
Dr. Asma Patel
VP, Integrated Development Services
Dr. Asma Patel is responsible for providing scientific and technical support to Quotient Sciences' business development group and ...
About AsmaJamie Weishaar
VP, Global Commercial Drug Product
Jamie Weishaar is an experienced business development executive leader specializing in pharmaceutical drug development, including ...
About JamieAmit Patel
Senior Director of Technical Services
Amit Patel, Senior Director of Technical Services, has held various technical and operational leadership roles during his 15-year ...
About AmitRobert Cornog
Senior Director, Product Development
Robert Cornog has over 26 years of experience in product development and process design. Across a broad range of dosage forms and ...
About RobertQuotient Sciences has multiple U.S. facilities where drug product manufacturing and clinical pharmacology are performed, as well as US-based business development and scientific teams. Quotient Sciences U.S. facilities are located in Boothwyn and Garnet Valley, Pennsylvania (both near Philadelphia in Eastern Pennsylvania) as well as in Miami, Florida.
From facilities located in the US and UK, Quotient Sciences offers coordinated contract research, development, and manufacturing services (CRO services and CDMO services) as part of one organization. Drug product manufacturing is performed at facilities in Nottingham and Reading, UK, and in the US from our two facilities located near Philadelphia, PA.
Good Manufacturing Practices (GMP) refer to the guidelines that ensure that pharmaceutical products are produced in a consistent way, maintaining quality standards. Also known as current Good Manufacturing Practices, or cGMP, these practices focus on ensuring safety, quality, and efficacy of drug products over the lifecycle of a drug. Quotient Sciences adheres to cGMP practices at all of our global pharma manufacturing facilities.
A CRDMO is a contract research, development, and manufacturing organization. A company that offers CRDMO services integrates different areas that would typically be found by selecting multiple vendors.